Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zohar

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Psychiatry|December 1, 1986
Utility of neuroleptic blood levels in the treatment of acute psychosisJ Zohar, Z Shemesh, R H Belmaker
Journal of Neuroendocrinology|December 14, 2011
Microinfusion of a corticotrophin-releasing hormone receptor 1 antisense oligodeoxynucleotide into the dorsal hippocampus attenuates stress responses at specific times after stress exposureN Kozlovsky, J Zohar, Z Kaplan, et al.
Harefuah|June 15, 1975
[Salivary enzyme activity in disorders of the parotid gland]J Zohar, J Rubinstein, L Geist, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patientD Amital, R Gross, H Amital, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatmentJ Zohar, D L Murphy, J N Crawley
The Journal of Urology|September 1, 1976
Factors influencing sexual activity after prostatectomy: a prospective studyJ Zohar, D Meiraz, B Maoz, et al.
General Hospital Psychiatry|May 16, 1998
Healing environment in psychiatric hospital designR Gross, Y Sasson, M Zarhy, et al.
Advances in Cyclic Nucleotide Research|January 1, 1980
Cyclic nucleotides in mental disorderR H Belmaker, J Zohar, R P Ebstein
Brain Research|March 31, 1987
Chronic lithium treatment increases the phosphorylation of a 64-kDa protein in rat brainsE Klein, J Patel, R McDevitt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptanL Stern, J Zohar, R Cohen, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Psychiatry|December 1, 1986
Utility of neuroleptic blood levels in the treatment of acute psychosisJ Zohar, Z Shemesh, R H Belmaker
Journal of Neuroendocrinology|December 14, 2011
Microinfusion of a corticotrophin-releasing hormone receptor 1 antisense oligodeoxynucleotide into the dorsal hippocampus attenuates stress responses at specific times after stress exposureN Kozlovsky, J Zohar, Z Kaplan, et al.
Harefuah|June 15, 1975
[Salivary enzyme activity in disorders of the parotid gland]J Zohar, J Rubinstein, L Geist, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1997
Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patientD Amital, R Gross, H Amital, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatmentJ Zohar, D L Murphy, J N Crawley
The Journal of Urology|September 1, 1976
Factors influencing sexual activity after prostatectomy: a prospective studyJ Zohar, D Meiraz, B Maoz, et al.
General Hospital Psychiatry|May 16, 1998
Healing environment in psychiatric hospital designR Gross, Y Sasson, M Zarhy, et al.
Advances in Cyclic Nucleotide Research|January 1, 1980
Cyclic nucleotides in mental disorderR H Belmaker, J Zohar, R P Ebstein
Brain Research|March 31, 1987
Chronic lithium treatment increases the phosphorylation of a 64-kDa protein in rat brainsE Klein, J Patel, R McDevitt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptanL Stern, J Zohar, R Cohen, et al.
Pageof 12